On the other hand, Lin et al. revealed that in hepatocellular carcinoma (HCC) chemerin may play a completely different role as a factor that negatively regulates tumor-associated inflammation, thereby inhibiting HCC progression. This evidence concerns the gene RARRES2 and hepatocellular carcinoma.